{"entities":{"Q9853":{"pageid":14014,"ns":120,"title":"Item:Q9853","lastrevid":205774,"modified":"2020-05-21T15:46:21Z","type":"item","id":"Q9853","labels":{"en":{"language":"en","value":"LoConte NK, et al. Invest. N. Drugs (2015) cited as Ref 590 in DOI: 10.1038/s41392-020-0110-5"}},"descriptions":{"en":{"language":"en","value":"Cited in: \"Targeting cancer stem cell pathways for cancer therapy\" in Signal Transduct Target Ther; 2020 ; 5 8"}},"aliases":[],"claims":{"P17":[{"mainsnak":{"snaktype":"value","property":"P17","datavalue":{"value":{"entity-type":"item","numeric-id":7916,"id":"Q7916"},"type":"wikibase-entityid"},"datatype":"wikibase-item"},"type":"statement","id":"Q9853$B71E2FF0-3C63-4E0F-BED7-876262E8E2AD","rank":"normal"}],"P94":[{"mainsnak":{"snaktype":"value","property":"P94","datavalue":{"value":{"entity-type":"item","numeric-id":8449,"id":"Q8449"},"type":"wikibase-entityid"},"datatype":"wikibase-item"},"type":"statement","id":"Q9853$796B386F-9ED1-4F86-92FA-E029A3E4F7FF","rank":"normal"}],"P149":[{"mainsnak":{"snaktype":"value","property":"P149","datavalue":{"value":"LoConte NK","type":"string"},"datatype":"string"},"type":"statement","id":"Q9853$24F10F7D-0094-4BB5-B09C-13951BB51B00","rank":"normal"}],"P138":[{"mainsnak":{"snaktype":"value","property":"P138","datavalue":{"value":"10.1007/s10637-014-0166-6","type":"string"},"datatype":"external-id"},"type":"statement","id":"Q9853$5C944CA7-DC16-434E-9CB7-77FAD40E286E","rank":"normal"}],"P100":[{"mainsnak":{"snaktype":"value","property":"P100","datavalue":{"value":{"time":"+2015-01-01T00:00:00Z","timezone":0,"before":0,"after":0,"precision":9,"calendarmodel":"http://www.wikidata.org/entity/Q1985727"},"type":"time"},"datatype":"time"},"type":"statement","id":"Q9853$F5947564-A6B0-4B17-8225-7B1C02A194CF","rank":"normal"}],"P102":[{"mainsnak":{"snaktype":"value","property":"P102","datavalue":{"value":"Invest. N. Drugs","type":"string"},"datatype":"string"},"type":"statement","id":"Q9853$8AFFD004-4422-4E50-8DA1-B338400270AB","rank":"normal"}],"P103":[{"mainsnak":{"snaktype":"value","property":"P103","datavalue":{"value":"33","type":"string"},"datatype":"string"},"type":"statement","id":"Q9853$7B85DCAD-14D0-453D-B84C-0EC4C88E773F","rank":"normal"}],"P93":[{"mainsnak":{"snaktype":"value","property":"P93","datavalue":{"value":{"text":"A multicenter phase 1 study of gamma -secretase inhibitor RO4929097 in combination with capecitabine in refractory solid tumors","language":"en"},"type":"monolingualtext"},"datatype":"monolingualtext"},"type":"statement","id":"Q9853$2917197A-B2E8-416A-9C48-75E7937A83CF","rank":"normal"}],"P105":[{"mainsnak":{"snaktype":"value","property":"P105","datavalue":{"value":"169-176","type":"string"},"datatype":"string"},"type":"statement","id":"Q9853$BB59804A-6A13-4FE0-AC60-8809699D895B","rank":"normal"}]},"sitelinks":{"sliswiki":{"site":"sliswiki","title":"LoConte NK, et al. Invest. N. Drugs (2015) cited as Ref 590 in DOI: 10.1038/s41392-020-0110-5","badges":[],"url":"https://wikibase.slis.ua.edu/wiki/LoConte_NK,_et_al._Invest._N._Drugs_(2015)_cited_as_Ref_590_in_DOI:_10.1038/s41392-020-0110-5"}}}}}